Savara updates corporate presentation; no material new disclosures

Savara Inc

Updated corporate presentation posted on IR page and furnished as Exhibit 99.1.
Presentation covers Savara's rare respiratory disease pipeline, no specific financial/operational updates provided.
No changes to guidance, pipeline status, or financial outlook disclosed in the filing.
Savara undertakes no obligation to update the presentation except through normal channels.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.